As Rakesh K. Jaina et al. reported, blocking CXCR4 by AMD3100 decreases immunosuppression in metastatic breast tumor largely through alleviating tumor desmoplasia and hypoxia16. This evidence concerns the gene CXCR4 and neoplasm.